Epic's dominance in the EHR market raises concerns about limited uptake of its consumer interface, stifling innovation and undermining breakthrough technologies.
The concentration of market share among a few vendors, like Epic, poses pricing concerns and hampers innovation and interoperability in the future of EHR systems.
Deep dives
Current Implications of Three Vendors Dominating EHR Market
The dominance of three EHR vendors, Epic, Cerner, and Meditech, controlling more than 75% of the market has significant implications. Epic is believed to have a larger market share than reported, possibly more than 50%, making it the most dominant player. However, concerns arise regarding Epic's consumer interface, MyChart, which has limited uptake and is considered cumbersome. Epic's market power and anti-competitive behavior are also evident, stifling innovation and limiting the ability of breakthrough technologies to enter the market. In contrast, Meditech's influence primarily comes from HCA, while Cerner is shrinking. Notably, Epic received an A-grade for its system compared to Meditech's B and Cerner's D+. Despite breakthroughs, such as a single Epic installation across Michigan's healthcare system, concerns remain about Epic's limited interoperability and its control over the market.
Future Implications of Three Vendors Dominating EHR Market
Looking ahead, the dominance of three vendors controlling more than 75% of the EHR market raises concerns about pricing and innovation. The concentration of market share in the hands of a few vendors, particularly Epic, raises worries about price gouging, especially for smaller healthcare organizations. Critical access hospitals and ambulatory care practices still have some competition and are less affected by vendor dominance. However, academic medical centers and children's hospitals face significant challenges. While Epic's recent partnerships and PALS program may foster innovation, they also create a closed system that limits access and blocks competition. The need for a more open and creative ecosystem is crucial for the future of EHR systems, as relying solely on Epic's control hampers innovation and interoperability.
Calls to Address Epic's Market Concentration
The increasing market concentration of Epic has raised calls for regulatory action. The FTC is urged to investigate Epic's policies, particularly regarding their app orchard, in order to ensure adherence to interoperability guidelines and prevent anti-competitive behavior. The aim is to create a level playing field and promote open access to patient data for innovative companies. Achieving a fully interoperable electronic health record system for everyone in the United States is not a technological impossibility but depends on the will of the business sector to prioritize interoperability and information exchange. Until then, the healthcare industry may continue to struggle in achieving efficient and seamless patient care.
Just three vendors control more than 75% of the EHR market. What are the current and future implications for patients and providers? David W. Johnson and Julie Murchinson discuss the pros and cons on the new episode of the 4sight Health Roundup podcast, moderated by David Burda.
David W. Johnson is CEO of 4sight Health.
Julie Vaughan Murchinson is Partner of Transformation Capital and former CEO of Health Evolution.
David Burda is News Editor and Columnist of 4sight Health.